Cargando…
Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
PURPOSE: The proportion of liver recipients with HCV is gradually increasing in Korea. Limited data are available regarding the efficacy of direct antiviral agents (DAAs) in liver transplant recipients in Asia. We aimed to assess the efficacy and safety of DAAs in HCV-infected liver recipients in Ko...
Autores principales: | Kim, Jong Man, Lee, Kwang-Woong, Sinn, Dong-Hyun, Choi, Gyu-Seong, Yi, Nam-Joon, Kwon, Choon Hyuck David, Suh, Kyung-Suk, Joh, Jae-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121168/ https://www.ncbi.nlm.nih.gov/pubmed/30182021 http://dx.doi.org/10.4174/astr.2018.95.3.147 |
Ejemplares similares
-
Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020) -
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
por: Kim, Jong Man, et al.
Publicado: (2016) -
Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study
por: Kim, Jong Man, et al.
Publicado: (2016) -
A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014) -
Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)